These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 7124176)

  • 21. Pathways to diagnosis of cervical cancer: screening history, delay in follow up, and smear reading.
    Priest P; Sadler L; Peters J; Crengle S; Bethwaite P; Medley G; Jackson R
    BJOG; 2007 Apr; 114(4):398-407. PubMed ID: 17166215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
    Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
    J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of the clinical evaluation of atypical glandular cells of undetermined significance (AGCUS) detected on cervical cytology screening.
    Kennedy AW; Salmieri SS; Wirth SL; Biscotti CV; Tuason LJ; Travarca MJ
    Gynecol Oncol; 1996 Oct; 63(1):14-8. PubMed ID: 8898161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing the feasibility of single lifetime PAP smear evaluation between 41-50 years of age as strategy for cervical cancer control in developing countries from our 32 years of experience of hospital-based routine cytological screening.
    Misra JS; Gupta HP; Das V
    Diagn Cytopathol; 2004 Dec; 31(6):376-9. PubMed ID: 15540174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001.
    van der Aa MA; Schutter EM; Looijen-Salamon M; Martens JE; Siesling S
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):204-9. PubMed ID: 18093720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Are analyses of cytological cervix smears from young women more harmful than beneficial?].
    Skjeldestad FE; Hagen B; Hagmar B; Iversen OE; Juvkam KH; Steen R; Thoresen S; Hareide B
    Tidsskr Nor Laegeforen; 2007 Jun; 127(13):1782-5. PubMed ID: 17599128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Less pap-2 results ('minor abnormalities') in the population screening for cervical cancer since the introduction of new guidelines in 1996].
    Bos AB; van Ballegooijen M; van den Akker-van Marle ME; Habbema JD
    Ned Tijdschr Geneeskd; 2002 Aug; 146(34):1586-90. PubMed ID: 12224483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening history of women in Malmö with invasive cervical cancer.
    Lindqvist PG; Hellsten C; Rippe A
    Eur J Obstet Gynecol Reprod Biol; 2008 Mar; 137(1):77-83. PubMed ID: 17210219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
    Liao SY; Stanbridge EJ
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cervical screening in elderly women in Singapore.
    Ho T; Yoong T
    Singapore Med J; 1996 Feb; 37(1):61-5. PubMed ID: 8783916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong.
    Kim JJ; Leung GM; Woo PP; Goldie SJ
    J Public Health (Oxf); 2004 Jun; 26(2):130-7. PubMed ID: 15284314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Proposal of cervical cancer early detection programme in Croatia].
    Znaor A; Babić D; Corusić A; Grce M; Mahovlić V; Pajtler M; Serman A
    Lijec Vjesn; 2007 May; 129(5):158-63. PubMed ID: 17695198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A hospital-based study on the use of paramedical personnel for clinical downstaging of cancer cervix.
    Bhargava VL; Verma K; Sharma R; Batra S; Anandalakshmy PN
    Indian J Med Res; 1993 Apr; 98():65-8. PubMed ID: 8344733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Influence of screening examinations on stage distributions of cervical carcinoma at a gynecological department ].
    Anderl P; Ledermair O
    Wien Med Wochenschr; 1982 Jun; 132(11):241-3. PubMed ID: 7123963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Conservative treatment of early cases of cervix carcinoma with trenimon].
    Krawczyk B
    Zentralbl Gynakol; 1968 Aug; 90(32):1084-6. PubMed ID: 5682203
    [No Abstract]   [Full Text] [Related]  

  • 36. [Sternberg '70--model of multiphase mass screening. I. Organization].
    Tredt HJ; Thiele HJ; Friedemann H; Brasch C
    Dtsch Gesundheitsw; 1972 Jun; 27(24):1138-45. PubMed ID: 5075395
    [No Abstract]   [Full Text] [Related]  

  • 37. Multiphasic screening as part of family doctoring.
    Bernstein JM; Dolan LJ
    Practitioner; 1969 Dec; 203(218):789-805. PubMed ID: 5356393
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of "superficial carcinoma" at the gynecological university clinic of Berlin (Charité)].
    Lisse K
    Arch Geschwulstforsch; 1963; 22(1):106-20. PubMed ID: 5890670
    [No Abstract]   [Full Text] [Related]  

  • 39. [Sternberg '70--model for multiphasic screening. 2. Initial results, after care program and diagnostic groupings].
    Tredt HJ; Ehrke D; Balzer H; Thiele HJ; Friedemann H; Brasch C
    Dtsch Gesundheitsw; 1972 Nov; 27(45):2143-8. PubMed ID: 4650686
    [No Abstract]   [Full Text] [Related]  

  • 40. [Standardization of multiphasic screening. I. Organization and choice of parameters].
    Thiele HJ; Friedemann H; Tredt HJ; Wagenknecht C; Hoffmann H
    Dtsch Gesundheitsw; 1972 May; 27(19):893-9. PubMed ID: 5041579
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.